INTERNATIONAL PATENT: VIVIDION THERAPEUTICS, INC., 维维迪恩医疗公司, WANG, YUANXIAN, 王苑先 FILES APPLICATION FOR "METHOD FOR CATALYTICALLY SYNTHESIZING SINGLE CHIRAL 2-ARYL-SUBSTITUTED NITROGEN HETEROCYCLIC DERIVATIVE BY MEANS OF IMINE REDUCTASE AND USE THEREOF"

Posted On: 2025-07-14

GENEVA, July 14 -- VIVIDION THERAPEUTICS, INC. (5820 Nancy Ridge Drive, San DiegoCalifornia 92121), 维维迪恩医疗公司 (美国加利福尼亚州圣地亚哥南希岭大道5820号), WANG, Yuanxian (81 Huasheng Road, Jiangbei New AreaNanjing, Jiangsu 210032), 王苑先 (中国江苏省南京市江北新区华盛路81号) filed a patent application (PCT/CN2025/070327) for "METHOD FOR CATALYTICALLY SYNTHESIZING SINGLE CHIRAL 2-ARYL-SUBSTITUTED NITROGEN HETEROCYCLIC DERIVATIVE BY MEANS OF IMINE REDUCTASE, AND USE THERE...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: VIVIDION THERAPEUTICS, INC., 维维迪恩医疗公司, WANG, YUANXIAN, 王苑先 FILES APPLICATION FOR "METHOD FOR CATALYTICALLY SYNTHESIZING SINGLE CHIRAL 2-ARYL-SUBSTITUTED NITROGEN HETEROCYCLIC DERIVATIVE BY MEANS OF IMINE REDUCTASE AND USE THEREOF"